Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur
Active, not recruitingOBSERVATIONAL
Enrollment
150
Participants
Timeline
Start Date
February 3, 2020
Primary Completion Date
February 29, 2032
Study Completion Date
August 31, 2032
Conditions
Knee OsteoarthritisTraumatic Arthritis of KneeAvascular NecrosisDegenerative Joint Disease of KneeRheumatoid Arthritis of KneeCorrection of Functional Deformity
Interventions
DEVICE
Primary Knee implants
Primary knee arthroplasty
Trial Locations (1)
48602
Covenant Medical Center, Saginaw
All Listed Sponsors
lead
MicroPort Orthopedics Inc.
INDUSTRY
NCT04301622 - Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur | Biotech Hunter | Biotech Hunter